Reliant Technologies Announces Canadian Launch of Fraxel re:pair(R) Laser: A New Class of Treatment Therapy for CO2 Laser Skin R...( Fraxel re:pair(R) system receives He...)
| HOME >> BIOLOGY >> TECHNOLOGY |
Fraxel re:pair(R) system receives Health Canada clearance to treat severe
sun damage, sagging skin, vascular dyschromia and wrinkles
MOUNTAIN VIEW, Calif., Aug. 19 /PRNewswire/ -- Reliant Technologies, Inc., the pioneer of fractional resurfacing and market leader of aesthetic laser skin treatments, today announced its Canadian launch of the Fraxel re:pair laser system with the recent Health Canada Clearance. The Canadian debut of the Fraxel re:pair system occurred at the recent Controversies and Conversations in Laser Cosmetic Surgery symposium in Whistler, B.C., Canada.
The Fraxel re:pair system is now available for purchase by dermatologists, plastic surgeons and cosmetic physicians in Canada. In December 2007, the Fraxel re:pair system received the industry's first FDA 510(K) clearance for a fractional ablative laser system for treatment of wrinkles, rhytides, furrows, fine lines, textural irregularities, pigmented lesions and vascular dyschromia.
The industry's first minimally invasive, ablative fractional laser system, the Fraxel re:pair laser delivers a full spectrum of aesthetic treatment from mild to aggressive. It is the only ablative resurfacing device capable of being operated by a single clinician because of its built-in smoke evacuation system, and capable of treating at depths from 110 micrometers (um) to 1.6 mm into the dermis.
"Ablative fractional skin resurfacing with the Fraxel re:pair laser is a major breakthrough for my patients who desire significant tissue tightening, wrinkle reduction, and improvement in skin quality, both on and off the face," said William McGillivray, MD, a director of Pacific Dermaesthetics in Vancouver, B.C.
Mark Lupin, MD, FRCPC, director of Cosmedica in Victoria, B.C., added, "The Fraxel re:pair system addresses the full range of photodamage - wrinkles, lines, pigment, and vascular irregularities, all in a single treatment."
The Fraxel re:pair laser system, the res
'/>"/>
| SOURCE Reliant Technologies, Inc. Copyright©2008 PR Newswire. All rights reserved |
Related biology technology :
1. Reliant Pharmaceuticals Announces the Filing of Registration Statement on Form S-1 For an Initial Public Offering
2. Palatin Technologies, Inc. Reports Positive Results of Phase 2a Clinical Study with PL-3994 for the Treatment of Heart Failure
3. RainDance Technologies Appoints Olex Vice President, System Development
4. BioSpecifics Technologies Corp. Reports Second Quarter 2008 Financial Results
5. Mark C. Mirken Named New CEO and Chairman of the Board of Millennium Biotechnologies, Inc.
6. ImmunoVaccine Technologies Broadens Its Patent Protection to Japan
7. Neurobiological Technologies Reports Receipt of $2.1 Million Royalty Payment for Quarterly Sales of Memantine
8. MaxWell Biocorporation, LLC, and International Medical Information Technologies, Inc., Announce Partnership
9. Senesco Technologies Announces Successful Completion of First Milestone Related to Agreement with Bayer CropScience
10. [video] Edward Spink, CEO of TurboSonic Technologies, Inc. Discusses Contract With Biofuel Producer in Exclusive Interview on WallSt.nets 3-Minute Press Show
11. Local officials move toward monitoring nanotechnologies
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |